Diet Doc Now Offers FDA Approved Injectable Saxenda for Weight Loss
Marketed under the name, Saxenda, Liraglutide, an injectable diabetes drug, was approved by the FDA in 2014 to treat those patients who have tried unsuccessfully to lose weight. After a one year study, which was published in the New England Journal of Medicine, reports reveal that the drug is, in fact, effective in treating uncontrolled weight gain, with study subjects losing an average of 18 pounds over a one-year period. Although many insurance companies initially hesitated to approve Saxenda for...
View full press release